Literature DB >> 19294463

Killing of Gram-negative bacteria with normal human serum and normal bovine serum: use of lysozyme and complement proteins in the death of Salmonella strains O48.

G Bugla-Płoskońska1, A Kiersnowski, B Futoma-Kołoch, W Doroszkiewicz.   

Abstract

Serum is an environment in which bacterial cells should not exist. The serum complement system provides innate defense against microbial infections. It consists of at least 35 proteins, mostly in pre-activated enzymatic forms. The activation of complement is achieved through three major pathways: the classical, alternative, and lectin. Lysozyme, widely present in body fluids, catalyzes the hydrolysis of beta 1,4 linkage between N-acetyloglucosamine and N-acetylmuramic acid in the bacterial cell wall and cooperates with the complement system in the bactericidal action of serum. In this study, ten strains of serotype O48 Salmonella, mainly associated with warm-blooded vertebrates and clinically important causing diarrhea in infants and children, were tested. The results demonstrated that the most efficient killing of Salmonella O48 occurred when all the components of normal bovine serum (NBS) and normal human serum (NHS) cooperated. To prove the role of lysozyme in the bactericidal activity of bovine and human serum, the method of serum adsorption onto bentonite (montmorillonite, MMT) was used. In order to investigate structural transitions accompanying the adsorption of serum components, we applied X-ray diffraction methods. The results of this investigation suggested that apart from lysozyme, other proteins (as, e.g., C3 protein or IgG immunoglobulin) were adsorbed on MMT particles. It was also shown that Ca(2+) cations can be adsorbed on bentonite. This may explain the different sensitivities of the serovars belonging to the same O48 Salmonella serotype to NBS and NHS devoid of lysozyme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294463     DOI: 10.1007/s00248-009-9503-2

Source DB:  PubMed          Journal:  Microb Ecol        ISSN: 0095-3628            Impact factor:   4.552


  46 in total

1.  Bactericidal activity of normal cord serum (NCS) against Gram-negative rods with sialic acid-containing lipopolysaccharides (LPS).

Authors:  G Mielnik; A Gamian; W Doroszkiewicz
Journal:  FEMS Immunol Med Microbiol       Date:  2001-10

2.  Rapid, room-temperature synthesis of antibacterial bionanocomposites of lysozyme with amorphous silica or titania.

Authors:  Heather R Luckarift; Matthew B Dickerson; Kenneth H Sandhage; Jim C Spain
Journal:  Small       Date:  2006-05       Impact factor: 13.281

Review 3.  Complement-mediated killing of susceptible gram-negative bacteria: an elusive mechanism.

Authors:  P W Taylor
Journal:  Exp Clin Immunogenet       Date:  1992

4.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

5.  Lysozyme association with nucleic acids.

Authors:  L K Steinrauf; D Shiuan; W J Yang; M Y Chiang
Journal:  Biochem Biophys Res Commun       Date:  1999-12-20       Impact factor: 3.575

6.  Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum.

Authors:  J A Odumeru; G M Wiseman; A R Ronald
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme.

Authors:  R J Martinez; S F Carroll
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

8.  Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides.

Authors:  N J Laible; G R Germaine
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

9.  A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.

Authors:  M O Ogundele
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

Review 10.  Viral mimicry of the complement system.

Authors:  John Bernet; Jayati Mullick; Akhilesh K Singh; Arvind Sahu
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

View more
  6 in total

1.  Reptiles as a source of Salmonella O48--clinically important bacteria for children: the relationship between resistance to normal cord serum and outer membrane protein patterns.

Authors:  Gabriela Bugla-Płoskońska; Agnieszka Korzeniowska-Kowal; Katarzyna Guz-Regner
Journal:  Microb Ecol       Date:  2010-05-18       Impact factor: 4.552

2.  Sialic acid-containing lipopolysaccharides of Salmonella O48 strains--potential role in camouflage and susceptibility to the bactericidal effect of normal human serum.

Authors:  Gabriela Bugla-Płoskońska; Jacek Rybka; Bozena Futoma-Kołoch; Agnieszka Cisowska; Andrzej Gamian; Włodzimierz Doroszkiewicz
Journal:  Microb Ecol       Date:  2009-10-21       Impact factor: 4.552

Review 3.  Applications of Lysozyme, an Innate Immune Defense Factor, as an Alternative Antibiotic.

Authors:  Patrizia Ferraboschi; Samuele Ciceri; Paride Grisenti
Journal:  Antibiotics (Basel)       Date:  2021-12-14

4.  Improvement of bacterial clearance and relief of clinical signs of Salmonella enterica serovar Typhimurium infection in pigs through upregulation of Th 1-specific responses by administration of a combination of two silicate minerals, biotite and bentonite.

Authors:  Jin-A Lee; Bock-Gie Jung; Tae-Hoon Kim; Yun-Mi Kim; Hong-Bum Koh; Bong-Joo Lee
Journal:  J Vet Med Sci       Date:  2015-05-04       Impact factor: 1.267

5.  Effects of Barranca yajiagengensis Powder in the Diet of Trachinotus ovatus on the Growth Performance, Antioxidant Capacity, Immunity and Morphology of the Liver and Intestine.

Authors:  Wei Zhao; Xin Cui; Zi-Qiao Wang; Rong Yao; Meng-Die Chen; Bao-Yan Gao; Cheng-Wu Zhang; Jin Niu
Journal:  Antioxidants (Basel)       Date:  2022-06-22

6.  Characterization of Global Gene Expression, Regulation of Metal Ions, and Infection Outcomes in Immune-Competent 129S6 Mouse Macrophages.

Authors:  Lara N Janiszewski; Michael Minson; Mary A Allen; Robin D Dowell; Amy E Palmer
Journal:  Infect Immun       Date:  2021-08-02       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.